$RGNX REGENXBIO Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in REGENXBIO Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in REGENXBIO Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in REGENXBIO Inc. for free.

CIK Number: 0001590877
IRS Number: 471851754
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: RGNX
Company Address: 9600 BLACKWELL ROAD SUITE 210 ROCKVILLE 20850
Phone number: 240-552-8181
Former name: REGENXBIO, Inc., date of change: 2015-01-16
Former name: ReGenX Biosciences, LLC, date of change: 2013-11-01

REGENXBIO, Inc. is a biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. The company was founded by Kennth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.

Market Capitalization: $465.96M
Prev close: $17.15
Average Daily Volume: 221,868
Days Low: $16.85
Year Low: $7.07
Year High: $24.55

REGENXBIO Inc. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
Christmas Patrick J.SVP, General Counsel6,547112,281shares bought: 76,865 / shares sold: -75,000 BUYApr 22 20191 month ago
Danos OlivierChief Scientific Officer8,500145,775shares bought: 28,500 / shares sold: -22,000 BUYApr 17 20191 month ago
Mills Kenneth T.President and CEO261,0004,476,150shares bought: 578,530 / shares sold: -327,970 STRONG BUYMay 22 20192 days ago
PAKOLA STEVEChief Medical Officer00Apr 19 20191 month ago
Simpson CurranSVP, Product Development & CTO44,800768,320shares bought: 262,823 / shares sold: -223,323 BUYFeb 27 20193 months ago
Vasista VittalChief Financial Officer230,9153,960,192shares bought: 315,701 / shares sold: -193,826 BUYMar 25 20192 months ago

View all REGENXBIO Inc. insiders.

REGENXBIO Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 22 2019RGNXREGENXBIO Inc.Mills Kenneth T.President and CEOOption ExerciseM0.8515,00012,750129,670
May 22 2019RGNXREGENXBIO Inc.Mills Kenneth T.President and CEOSellS43.9930013,197246,000246.3 K to 246 K (-0.12 %)
May 22 2019RGNXREGENXBIO Inc.Mills Kenneth T.President and CEOSellS43.3210,559457,416246,300256.9 K to 246.3 K (-4.11 %)
May 22 2019RGNXREGENXBIO Inc.Mills Kenneth T.President and CEOSellS42.084,141174,253256,859261 K to 256.9 K (-1.59 %)
May 22 2019RGNXREGENXBIO Inc.Mills Kenneth T.President and CEOBuyM0.8515,00012,750261,000246 K to 261 K (+6.10 %)
Apr 24 2019RGNXREGENXBIO Inc.Mills Kenneth T.President and CEOOption ExerciseM0.8515,00012,750144,670
Apr 24 2019RGNXREGENXBIO Inc.Mills Kenneth T.President and CEOSellS53.051005,305246,000246.1 K to 246 K (-0.04 %)
Apr 24 2019RGNXREGENXBIO Inc.Mills Kenneth T.President and CEOSellS52.331,30068,029246,100247.4 K to 246.1 K (-0.53 %)
Apr 24 2019RGNXREGENXBIO Inc.Mills Kenneth T.President and CEOSellS51.073,270166,999247,400250.7 K to 247.4 K (-1.30 %)
Apr 24 2019RGNXREGENXBIO Inc.Mills Kenneth T.President and CEOSellS50.316,929348,598250,670257.6 K to 250.7 K (-2.69 %)
Apr 24 2019RGNXREGENXBIO Inc.Mills Kenneth T.President and CEOSellS49.293,401167,635257,599261 K to 257.6 K (-1.30 %)
Apr 24 2019RGNXREGENXBIO Inc.Mills Kenneth T.President and CEOBuyM0.8515,00012,750261,000246 K to 261 K (+6.10 %)
Apr 22 2019RGNXREGENXBIO Inc.Christmas Patrick J.SVP, General Counse ...Option ExerciseM19.501,45928,4519,641
Apr 22 2019RGNXREGENXBIO Inc.Christmas Patrick J.SVP, General Counse ...Option ExerciseM12.103,54142,84649,931
Apr 22 2019RGNXREGENXBIO Inc.Christmas Patrick J.SVP, General Counse ...SellS55.501005,5503,0063.1 K to 3 K (-3.22 %)

View all REGENXBIO Inc. insider transactions.